Description

6-Acetyl-7-Fluoro-4H-Benzo[1,4]Oxazin-3-One is a high-purity fluorinated heterocyclic building block of significant interest in advanced organic synthesis. This compound matters as a key intermediate for constructing complex molecular architectures, particularly in the development of novel active pharmaceutical ingredients (APIs). It is primarily needed by research institutions and manufacturers in the pharmaceutical and agrochemical sectors for drug discovery and process chemistry applications. The CAS number for this compound is 1613720-26-5.

Application

This specialized intermediate is designed for high-value synthesis applications, including:

• Pharmaceutical Intermediate: A critical building block in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders and other therapeutic areas.
• Agrochemical Research: Used in the development of new-generation herbicides and pesticides, where the fluorine atom and benzoxazinone core can impart desirable biological activity and stability.
• Material Science Precursor: Serves as a starting material for creating advanced organic electronic materials and functional dyes.
• Academic & Contract Research: Essential for medicinal chemistry programs and process research & development (PR&D) in both academic and industrial settings.
• Custom Synthesis: A versatile substrate for further functionalization, enabling the creation of proprietary chemical libraries for high-throughput screening.

Basic Information

Product Name	6-Acetyl-7-Fluoro-4H-Benzo[1,4]Oxazin-3-One
CAS No.	1613720-26-5
Molecular Formula	C₁₀H₆FNO₃
Molecular Weight	207.16 g/mol
Synonyms	6-Acetyl-7-fluoro-3,4-dihydro-1,4-benzoxazin-3-one; 7-Fluoro-6-acetyl-4H-1,4-benzoxazin-3-one; 1613720-26-5; 6-Acetyl-7-fluoro-4H-benzo[d][1,4]oxazin-3-one; 3H-1,4-Benzoxazin-3-one, 6-acetyl-7-fluoro-3,4-dihydro-; Fluorinated benzoxazinone derivative
EINECS	Contact for details

Quality Control

Our production of 6-Acetyl-7-Fluoro-4H-Benzo[1,4]Oxazin-3-One adheres to stringent quality management protocols. Every batch undergoes comprehensive analytical characterization, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide a detailed Certificate of Analysis (COA) with each shipment, documenting all critical quality attributes. Our facilities operate under a quality system designed to meet the rigorous standards required for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at a controlled room temperature (typically 15-25°C). This compound may be light-sensitive and should be handled under appropriate conditions to maintain stability. Keep away from strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.